Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
| Period | Value | YoY Change |
|---|---|---|
| TTM | $199.51M | -4.7% |
| 2024 | $209.31M | -8.4% |
| 2023 | $228.63M | +0.3% |
| 2022 | $228.01M | -21.6% |
| 2021 | $290.96M | -16.0% |
| 2020 | $346.55M | +43.5% |
| 2019 | $241.47M | +18.0% |
| 2018 | $204.59M | +21.1% |
| 2017 | $168.98M | +121.9% |
| 2016 | $76.15M | - |